SCHOTT Pharma AG & Co KgaA
SCHOTT Pharma AG & Co's GHG Emissions Data Preview
In 2024, SCHOTT Pharma AG & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
SCHOTT Pharma AG & Co has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind SCHOTT Pharma AG & Co’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SCHOTT Pharma AG & Co’s data sources below and access millions more through our Disclosure Search.
Insights into SCHOTT Pharma AG & Co's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Co amounted to 71,477 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Co decreased by 3.16%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
SCHOTT Pharma AG & Co's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are SCHOTT Pharma AG & Co's Scope 1 emissions?
In 2024, the total Scope 1 emissions of SCHOTT Pharma AG & Co were 27,536 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), SCHOTT Pharma AG & Co's Scope 1 emissions decreased by 8.9%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are SCHOTT Pharma AG & Co's Scope 2 emissions?
In 2024, SCHOTT Pharma AG & Co reported Scope 2 greenhouse gas (GHG) emissions of 60 tCO₂e using the market-based method and 43,941 tCO₂e using the location-based method. a
Has SCHOTT Pharma AG & Co reduced its Scope 2 emissions over time?
Compared to the previous year (2023), SCHOTT Pharma AG & Co's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that SCHOTT Pharma AG & Co 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does SCHOTT Pharma AG & Co use for Scope 2 reporting?
In 2024, SCHOTT Pharma AG & Co reported its Scope 2 emissions using the market-based method and using the location-based method. a
SCHOTT Pharma AG & Co's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into SCHOTT Pharma AG & Co's Value Chain Emissions
In 2024, SCHOTT Pharma AG & Co reported 398,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of SCHOTT Pharma AG & Co includes a breakdown across 5 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
SCHOTT Pharma AG & Co's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are SCHOTT Pharma AG & Co's Scope 3 emissions?
In 2024, SCHOTT Pharma AG & Co reported total Scope 3 emissions of 398,000 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 90.32% of these emissions originated from upstream activities such as purchased goods and capital goods, while 9.68% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2023), SCHOTT Pharma AG & Co's Scope 3 emissions remained relatively stable, indicating that SCHOTT Pharma AG & Co 's emissions have plateaued with no significant change in its value chain footprint. a
What categories of Scope 3 emissions does SCHOTT Pharma AG & Co disclose?
In 2024, SCHOTT Pharma AG & Co reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of SCHOTT Pharma AG & Co's Scope 3 emissions?
In 2024, the largest contributors to SCHOTT Pharma AG & Co's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 212,000 tCO₂e (68.39%)
- Capital Goods (Cat. 2): 48,000 tCO₂e (15.48%)
- Investments (Cat. 15): 30,000 tCO₂e (9.68%)
SCHOTT Pharma AG & Co's Scope 3 Emissions by Categories
Insights into SCHOTT Pharma AG & Co’s GHG Emissions Intensity Compared to Industry Peers
In 2024, SCHOTT Pharma AG & Co reported Scope 1 greenhouse gas (GHG) emissions of 27,536 tCO₂e and total revenues of USD 1,069 millions. This translates into an emissions intensity of 25.76 tCO₂e per millions USD. a
SCHOTT Pharma AG & Co's Scope 1 Emissions Intensity Compared to Peers
How does SCHOTT Pharma AG & Co's GHG emissions intensity compare to its peers?
In 2024, SCHOTT Pharma AG & Co reported a Scope 1 emissions intensity of 25.76 tCO₂e per millions USD. Compared to the peer group median of 5.04 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does SCHOTT Pharma AG & Co rank on GHG emissions intensity within its industry?
In 2024, SCHOTT Pharma AG & Co ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places SCHOTT Pharma AG & Co among the least efficient performers, with one of the highest emissions intensities in its sector. a
Insights into SCHOTT Pharma AG & Co's Total Carbon Footprint
In 2024, SCHOTT Pharma AG & Co reported a total carbon footprint of 469,477 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.54% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output. a
The largest contributor to SCHOTT Pharma AG & Co's total carbon footprint was Scope 3 emissions, accounting for 84.78% of the company's total carbon footprint, followed by Scope 2 emissions at 9.36%. a